Latest Star Scientific Inc. Stories
GLEN ALLEN, Va., May 14 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) issued the following statement by the company's Chairman and President, Paul L. Perito: (Logo: http://www.newscom.com/cgi-bin/prnh/20090317/STARSCIENTIFICLOGO ) We received notice today from the US Patent & Trademark Office that it was terminating the reexamination of Claims 4, 12 and 20 of the "649" patent and claim 41 of the "401" patent that had been requested by RJ Reynolds in early 2009. The...
GLEN ALLEN, Va., May 10 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) filed its first-quarter financial report on Form 10-Q today with the Securities & Exchange Commission. The company reported revenue for the first quarter of $0.2 million and a net loss of $4.9 million. Star also reported positive working capital of $16.0 million as of March 31, which includes $20.7 million in cash and cash equivalents. The company stated that losses generated from operating...
GLEN ALLEN, Va., April 26 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) issued the following statement today by Paul L. Perito, the company's Chairman, President and COO: "We observed the publication of a study on accidental ingestion of tobacco products by children on Monday, April 19, and the subsequent media campaign, with mounting disbelief. The study, published in the online edition of the journal Pediatrics, purports to "assess the potential toxicity of novel...
GLEN ALLEN, Va., April 7 /PRNewswire-FirstCall/ -- Star Scientific (Nasdaq: CIGX) announced today that it has completed a "Research and Royalty Agreement" with the Roskamp Institute's affiliate, SRQ Bio, LLC, under which the Institute will conduct research on a compound developed by the company's Rock Creek Pharmaceutical subsidiary that medical researchers at the Institute believe may have an application in the treatment of Alzheimer's disease. Preliminary testing of the compound has...
GLEN ALLEN, Va., March 16 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) filed its annual report on Form 10-K today with the Securities and Exchange Commission. The company reported net sales of $0.7 millions for 2009 compared to $0.5 million in total sales for the previous year. Cash and cash equivalents at year-end 2009 totaled $12.4 million compared with $6.5 million at year-end 2008. The net loss for 2009 totaled approximately $(22.8) million compared to a net loss of...
GLEN ALLEN, Va., Feb. 22 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) announced that on Friday, February 19 the company filed an application with the Food & Drug Administration for approval to market Ariva-BDL(TM) as a "modified risk" tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009. This submission is the first such application to be filed with the Tobacco Products Center of the FDA, which has been established to oversee all aspects...
PETERSBURG, Va., Dec. 23 /PRNewswire/ -- Star Scientific Inc. (Nasdaq: CIGX) yesterday filed a notice of appeal in the company's patent infringement lawsuit against RJ Reynolds Tobacco Company (RJR). The notice of appeal, which was filed in the US District Court for Maryland, states that Star is appealing to the US Court of Appeals for the Federal Circuit the judgment, orders and decisions specified in the notice, including the judgment resulting from the June, 2009 jury verdict in favor of...
PETERSBURG, Va., Dec. 22 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) was notified yesterday that rulings had been entered by the US District Court for Maryland relating to the company's patent infringement lawsuit against RJ Reynolds Tobacco Company (RJR). Star had filed a Motion for Judgment as a Matter of Law or, In the Alternative, A New Trial, following the June, 2009 jury verdict in favor of RJR. Last month RJR also filed a motion with the Court seeking attorneys'...
PETERSBURG, Va., Dec. 1 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) issued the following statement this morning by Paul L. Perito, Esq., the company's Chairman, President and Chief Operating Officer: (Logo: http://www.newscom.com/cgi-bin/prnh/20090317/STARSCIENTIFICLOGO ) "We were advised by counsel late yesterday that RJ Reynolds Tobacco (RJR) had filed a Motion for Attorneys Fees and Excess Costs, as well as a Bill of Costs, with the US District Court for Maryland. We...
PETERSBURG, Va., Nov. 23 /PRNewswire-FirstCall/ -- Star Scientific, Inc. has announced that effective at the market opening on Monday, November 23, the NASDAQ trading symbol used by the company, STSI, is being changed to CIGX. Paul L. Perito, Star's Chairman, commented that "the change in trading symbol reflects our intent to signal more prominently the company's core mission and business, which is to reduce the harm associated with tobacco use. We have stated since the beginning that the...
